"CML Advocates Network" fosters collaboration of patient groups
world-wide, welcomes iCMLf launch
Patient groups representing rare cancers like leukaemia greatly benefit from sharing knowledge as well as collaborating with other groups and the oncology community. The CML Advocates Network, founded in 2007, is both a virtual network and an internet platform, now connecting 42 leukemia patient groups from 32 countries.